Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 152 No. 0506 (2022)

Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectives

  • Benoit Lechartier
  • Ari Chaouat
  • John-David Aubert
  • Juerg Schwitter
DOI
https://doi.org/10.4414/SMW.2022.w30055
Cite this as:
Swiss Med Wkly. 2022;152:w30055
Published
08.02.2022

Summary

Pulmonary hypertension is an heterogeneous group of diseases characterised by increased pulmonary arterial pressures which impact on the upstream right ventricle. Pulmonary hypertension can be challenging to diagnose, classify and monitor when specific therapies are applicable. Cardiac magnetic resonance (CMR) imaging has greatly evolved in the last decades and is a promising tool to non-invasively follow pulmonary hypertension patients. CMR provides a comprehensive evaluation of the heart and is therefore the gold standard for quantification of right ventricular volumes, mass and function, which are critical for pulmonary hypertension prognosis. In addition, innovative MR techniques allow an increasingly precise evaluation of pulmonary haemodynamics and lung perfusion. This review highlights the main advantages offered by CMR in pulmonary hypertension and gives an overview of putative future applications. Although right heart catheterisation remains mandatory in the diagnostic algorithm, CMR could play an increasingly important role in the coming years in monitoring pulmonary hypertension patients.

References

  1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015 Oct;46(4):903–75. https://doi.org/10.1183/13993003.01032-2015
  2. Wijeratne DT, Lajkosz K, Brogly SB, Lougheed MD, Jiang L, Housin A, et al. Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada. Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e003973. https://doi.org/10.1161/CIRCOUTCOMES.117.003973
  3. Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019 Jan;53(1):1801914. https://doi.org/10.1183/13993003.01914-2018
  4. Vachiéry JL, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, et al. Pulmonary hypertension due to left heart disease. Eur Respir J. 2019 Jan;53(1):1801897. https://doi.org/10.1183/13993003.01897-2018
  5. Naeije R, Badagliacca R. The overloaded right heart and ventricular interdependence. Cardiovasc Res. 2017 Oct;113(12):1474–85. https://doi.org/10.1093/cvr/cvx160
  6. Fourie PR, Coetzee AR, Bolliger CT. Pulmonary artery compliance: its role in right ventricular-arterial coupling. Cardiovasc Res. 1992 Sep;26(9):839–44. https://doi.org/10.1093/cvr/26.9.839
  7. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019 Jan;53(1):1801913. https://doi.org/10.1183/13993003.01913-2018
  8. Aryal SR, Sharifov OF, Lloyd SG. Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension. Eur Respir Rev. 2020 Jul;29(156):190138. https://doi.org/10.1183/16000617.0138-2019
  9. Alabed S, Garg P, Johns CS, Alandejani F, Shahin Y, Dwivedi K, et al. Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update. Curr Cardiovasc Imaging Rep. 2020;13(12):30. https://doi.org/10.1007/s12410-020-09550-2
  10. Wessels JN, de Man FS, Vonk Noordegraaf A. The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting? Eur Respir Rev. 2020 Jul;29(156):200139. https://doi.org/10.1183/16000617.0139-2020
  11. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007 May;28(10):1250–7. https://doi.org/10.1093/eurheartj/ehl477
  12. van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol. 2011 Dec;58(24):2511–9. https://doi.org/10.1016/j.jacc.2011.06.068
  13. Swift AJ, Wild JM, Nagle SK, Roldán-Alzate A, François CJ, Fain S, et al. Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art. J Thorac Imaging. 2014 Mar;29(2):68–79. https://doi.org/10.1097/RTI.0000000000000079
  14. Kiely DG, Levin D, Hassoun P, Ivy DD, Jone PN, Bwika J, et al. EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulm Circ. 2019 Mar;9(3):2045894019841990. https://doi.org/10.1177/2045894019841990
  15. Schwitter J, Nagel E. Volumes, Function, and Deformation: Left and Right Ventricles and Atria. In: CMR-Update, 3rd edition [Internet]. Lausanne, Switzerland; 2020. Available from: www.herz-mri.ch
  16. Vonk Noordegraaf A, Chin KM, Haddad F, Hassoun PM, Hemnes AR, Hopkins SR, et al. Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J. 2019 Jan;53(1):1801900. https://doi.org/10.1183/13993003.01900-2018
  17. Frost A, Badesch D, Gibbs JS, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019 Jan;53(1):1801904. https://doi.org/10.1183/13993003.01904-2018
  18. Lechartier B, Humbert M. Pulmonary arterial hypertension in systemic sclerosis. Presse Med. 2021 Feb;50(1):104062. https://doi.org/10.1016/j.lpm.2021.104062
  19. Brugger N, Lichtblau M, Maeder M, Muller H, Pellaton C, Yerly P ; Swiss Society For Pulmonary Hypertension SSPH. Two-dimensional transthoracic echocardiography at rest for the diagnosis, screening and management of pulmonary hypertension. Swiss Med Wkly. 2021 Jun;151(2122):w20486 https://smw.ch/article/doi/smw.2021.20486
  20. Ibrahim SH, White RD. Cardiovascular magnetic resonance for the assessment of pulmonary arterial hypertension: toward a comprehensive CMR exam. Magn Reson Imaging. 2012 Oct;30(8):1047–58. https://doi.org/10.1016/j.mri.2012.03.001
  21. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006 Dec;48(12):2546–52. https://doi.org/10.1016/j.jacc.2006.07.061
  22. Ginoux M, Cottin V, Glérant JC, Traclet J, Philit F, Sénéchal A, et al. Safety of right heart catheterization for pulmonary hypertension in very elderly patients. Pulm Circ. 2018 Oct-Dec;8(4):2045894018799272. https://doi.org/10.1177/2045894018799272
  23. Deaño RC, Glassner-Kolmin C, Rubenfire M, Frost A, Visovatti S, McLaughlin VV, et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med. 2013 May;173(10):887–93. https://doi.org/10.1001/jamainternmed.2013.319
  24. Remy-Jardin M, Ryerson CJ, Schiebler ML, Leung AN, Wild JM, Hoeper MM, et al. Imaging of Pulmonary Hypertension in Adults: A Position Paper from the Fleischner Society. Radiology. 2021 Mar;298(3):531–49. https://doi.org/10.1148/radiol.2020203108
  25. Delcroix M, Torbicki A, Gopalan D, Sitbon O, Klok FA, Lang I, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021 Jun;57(6):2002828. https://doi.org/10.1183/13993003.02828-2020
  26. Ascha M, Renapurkar RD, Tonelli AR. A review of imaging modalities in pulmonary hypertension. Ann Thorac Med. 2017 Apr-Jun;12(2):61–73. https://doi.org/10.4103/1817-1737.203742
  27. Johns CS, Wild JM, Rajaram S, Tubman E, Capener D, Elliot C, et al. Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI. Radiology. 2018 Oct;289(1):61–8. https://doi.org/10.1148/radiol.2018180120
  28. Humbert M, Lau EM, Montani D, Jaïs X, Sitbon O, Simonneau G. Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation. 2014 Dec;130(24):2189–208. https://doi.org/10.1161/CIRCULATIONAHA.114.006974
  29. Sitbon O, Gomberg-Maitland M, Granton J, Lewis MI, Mathai SC, Rainisio M, et al. Clinical trial design and new therapies for pulmonary arterial hypertension. Eur Respir J. 2019 Jan;53(1):1801908. https://doi.org/10.1183/13993003.01908-2018
  30. Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017 Aug;50(2):1700889. https://doi.org/10.1183/13993003.00889-2017
  31. van Wolferen SA, van de Veerdonk MC, Mauritz GJ, Jacobs W, Marcus JT, Marques KM, et al. Clinically significant change in stroke volume in pulmonary hypertension. Chest. 2011 May;139(5):1003–9. https://doi.org/10.1378/chest.10-1066
  32. Peacock AJ, Crawley S, McLure L, Blyth KG, Vizza CD, Poscia R, et al. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging. 2014 Jan;7(1):107–14. https://doi.org/10.1161/CIRCIMAGING.113.000629
  33. Sanz J, García-Alvarez A, Fernández-Friera L, Nair A, Mirelis JG, Sawit ST, et al. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart. 2012 Feb;98(3):238–43. https://doi.org/10.1136/heartjnl-2011-300462
  34. Lewis RA, Johns CS, Cogliano M, Capener D, Tubman E, Elliot CA, et al. Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020 Feb;201(4):458–68. https://doi.org/10.1164/rccm.201909-1771OC
  35. Alabed S, Shahin Y, Garg P, Alandejani F, Johns CS, Lewis RA, et al. Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2020 Sep.
  36. Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot CA, et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson. 2012 Jun;14(1):40. https://doi.org/10.1186/1532-429X-14-40
  37. Creuzé N, Hoette S, Montani D, Günther S, Lau E, Ternacle J, et al. Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension. Can J Cardiol. 2015 Dec;31(12):1469–76. https://doi.org/10.1016/j.cjca.2015.04.014
  38. Johns CS, Kiely DG, Rajaram S, Hill C, Thomas S, Karunasaagarar K, et al. Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models. Radiology. 2019 Jan;290(1):61–8. https://doi.org/10.1148/radiol.2018180603
  39. Whitfield AJ, Solanki R, Johns CS, Kiely D, Wild J, Swift AJ. MRI Prediction of Precapillary Pulmonary Hypertension according to the Sixth World Symposium on Pulmonary Hypertension. Radiology. 2020 Feb;294(2):482–482. https://doi.org/10.1148/radiol.2019192078
  40. Reiter U, Kovacs G, Reiter C, Kräuter C, Nizhnikava V, Fuchsjäger M, et al. MR 4D flow-based mean pulmonary arterial pressure tracking in pulmonary hypertension. Eur Radiol. 2021 Apr;31(4):1883–93. https://doi.org/10.1007/s00330-020-07287-6
  41. Ikoma T, Suwa K, Sano M, Ushio T, Saotome M, Ogawa N, et al. Early changes of pulmonary arterial hemodynamics in patients with systemic sclerosis: flow pattern, WSS, and OSI analysis with 4D flow MRI. Eur Radiol. 2021 Jun;31(6):4253–63. https://doi.org/10.1007/s00330-020-07301-x
  42. Rogers T, Ratnayaka K, Khan JM, Stine A, Schenke WH, Grant LP, et al. CMR fluoroscopy right heart catheterization for cardiac output and pulmonary vascular resistance: results in 102 patients. J Cardiovasc Magn Reson. 2017 Jul;19(1):54. https://doi.org/10.1186/s12968-017-0366-2
  43. Knight DS, Kotecha T, Martinez-Naharro A, Brown JT, Bertelli M, Fontana M, et al. Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment - predictors of procedure success and duration in pulmonary artery hypertension. J Cardiovasc Magn Reson. 2019 Sep;21(1):57. https://doi.org/10.1186/s12968-019-0569-9
  44. Ratnayaka K, Kanter JP, Faranesh AZ, Grant EK, Olivieri LJ, Cross RR, et al. Radiation-free CMR diagnostic heart catheterization in children. J Cardiovasc Magn Reson. 2017 Sep;19(1):65. https://doi.org/10.1186/s12968-017-0374-2
  45. Schoenfeld C, Cebotari S, Hinrichs J, Renne J, Kaireit T, Olsson KM, et al. MR Imaging-derived Regional Pulmonary Parenchymal Perfusion and Cardiac Function for Monitoring Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Pulmonary Endarterectomy. Radiology. 2016 Jun;279(3):925–34. https://doi.org/10.1148/radiol.2015150765
  46. Ota H, Sugimura K, Miura M, Shimokawa H. Four-dimensional flow magnetic resonance imaging visualizes drastic change in vortex flow in the main pulmonary artery after percutaneous transluminal pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Eur Heart J. 2015 Jul;36(25):1630. https://doi.org/10.1093/eurheartj/ehv054
  47. Schoenfeld C, Hinrichs JB, Olsson KM, Kuettner MA, Renne J, Kaireit T, et al. Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients. Eur Radiol. 2019 Apr;29(4):1693–702. https://doi.org/10.1007/s00330-018-5696-4
  48. Kaireit TF, Voskrebenzev A, Gutberlet M, Freise J, Jobst B, Kauczor HU, et al. Comparison of quantitative regional perfusion-weighted phase resolved functional lung (PREFUL) MRI with dynamic gadolinium-enhanced regional pulmonary perfusion MRI in COPD patients. J Magn Reson Imaging. 2019 Apr;49(4):1122–32. https://doi.org/10.1002/jmri.26342
  49. Pöhler GH, Klimes F, Voskrebenzev A, Behrendt L, Czerner C, Gutberlet M, et al. Chronic Thromboembolic Pulmonary Hypertension Perioperative Monitoring Using Phase-Resolved Functional Lung (PREFUL)-MRI. J Magn Reson Imaging. 2020 Aug;52(2):610–9. https://doi.org/10.1002/jmri.27097

Most read articles by the same author(s)